Angiotensinogen gene haplotype and hypertension: Interaction with ACE gene I allele

Hypertension

Volumn 41, Issue 1, 2003, Pages 9-15

  Tsai, Chia Ti ^a   Fallin, Daniele ^b   Chiang, Fu Tien ^a   Hwang, Juey Jen ^a   Lai, Ling Ping ^a   Hsu, Kuan Lih ^a   Tseng, Chuen Den ^a   Liau, Chiau Suong ^a   Tseng, Yung Zu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Genetics; Haplotypes; Hypertension, genetic; Polymorphism; Receptors, angiotensin II

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EPISTASIS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TAIWAN;

ALLELES; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN;

EID: 0037217399     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000045080.28739.12     Document Type: Article

References (28)

1. Morise T, Takeuchi Y, Takeda R. Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet. 1994;343:125.
2. Chiang FT, Lai ZP, Chem TH, Tseng CD, Hsu KL, Lo HM, Tseng YZ. Lack of association of angiotensin converting enzyme polymorphism with essential hypertension in a Chinese population. Am J Hypertens. 1997;10:197-201.
3. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH, Tseng YZ. Molecular variant of M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens. 1997;15:607-611.
4. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension. 1995;25:688-693.
5. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JE, Brown MJ. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens. 1995;13:1602-1609.
6. Zhang X, Erdmann J, Regitz-Zagrosek V, Kurzinger S, Hense HW, Schunkert H. Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene. J Hypertens. 2000;18:267-272.
7. Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley J, Finch KL, Stevens JF, Livak KJ, Slotterbeck BD, Slifer SH, Warren LL, Conneally PM, Schmechel DE, Purvis I, Pericak-Vance MA, Roses AD, Vance JM. SNPing away at complex disease: analysis of singe-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet. 2000;67:383-394.
8. Long J, Williams R, Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotype. Am J Hum Genet. 1995;56:799-810.
9. Fallin D, Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet. 2000;67:947-959.
10. Schipper RF, D'Amaro J, de Lange P, Schreuder GM, van Rood JJ, Oudshoorn M. Validation of haplotype frequency estimation methods. Hum Immunol. 1998;59:518-523.
11. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, Schork NJ. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res. 2001;11:143-151.
12. Chiang FT, Hsu KL, Chen WM, Tseng CD, Tseng YZ. Determination of angiotensin-converting enzyme gene polymorphism: stepdown PCR increases detection of heterozygotes. Clin Chem. 1998;44:1353-1356.
13. Hilgers KF, Langenfeld MR, Schlaich M, Veelken R, Schmieder RE. 1166 A/C polymorphism of the angiotensin II type I receptor gene and the response to short-term infusion of angiotensin II. Circulation. 1999;100:1394-1399.
14. Yanai K, Saito T, Hirota K, Kobayashi H, Murakami K, Fukamizu A. Molecular variation of the human angiotensinogen core promoter element located between TATA box and transcriptional initiation site affects its transcriptional activity. J Biol Chem. 1997;272:30558-30562.
15. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786-1797.
16. Zhao YY. Zhou J, Narayanan CS, Cui Y, Kumar A. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension. 1999;33:108-115.
17. Wu SJ, Chiang FT, Jiang JR, Hsu KL, Chen TH, Tseng YZ. Molecular variants of Angiotensinogen gene promoter affect in vitro basal transcription. In: The International Session of the 24th Annual Scientific Meeting of the Japanese Society of Hypertension. Program and Abstracts. Tokyo: Japanese Society of Hypertension; 2002:197. Abstract.
18. Lewontin RC. On measures of gametic disequilibrium. Genetics. 1988;120:849-852.
19. Weir BS. Genetic Data Analysis II. Sunderland, Mass: Sinauer Associates; 1996.
20. Williams SM, Addy JH, Phillips JA 3rd, Dai M, Kpodonu J, Afful J, Jackson H, Joseph K, Eason F, Murray MM, Epperson P, Aduonum A, Wong LJ, Jose PA, Felder RA. Combination of variations in multiple genes are associated with hypertension. Hypertension. 2000;36:2-6.
21. Nakajima T, Jorde LB, Ishigami T, Umemura S, Emi M, Lalouel JM, Inoue I. Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet. 2002;70:108-123.
22. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, Lalouel JM. Haplotypes of Angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60:1448-1460.
23. Sato N, Katsuya T, Nakagawa T, Ishikawa K, Fu Y, Asai T, Fukuda M, Suzuki F, Nakamura Y, Higaki J, Ogihara T. Nine polymorphism of angiotensinogen gene in the susceptibility of essential hypertension. Life Sci. 2000;68:259-272.
24. Hernandez JL, Elston RC, Ward LJ. Gamet disequilibrium between 24 polymorphis markers. Hum Genet. 1990;85:343-348.
25. Morris BJ, Zee RY, Ying LH, Griffiths LR. Independent, marked association of alleles of the insulin receptor and dipeptidyl carboxypeptidase-I genes with essential hypertension. Clin Sci. 1993;85:189-195.
26. Panahloo A, Andres C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE, Yudkin JS. The insertion allele of the ACE gene I/D polymorphism: a candidate gene for insulin resistance? Circulation. 1995;92:3390-3393.
27. Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA. Renin-angiotensin system gene polymorphism, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese. Diabetes care. 2001;24:356-361.
28. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet. 1999;65:220-228.